Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer

about

Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer

Item

http://www.wikidata.org/entity/Q35770292

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Effect of Unblinding on Partic ...... Chemotherapy for Breast Cancer

@ast

Effect of Unblinding on Partic ...... Chemotherapy for Breast Cancer

@en

type

Item

label

Effect of Unblinding on Partic ...... Chemotherapy for Breast Cancer

@ast

Effect of Unblinding on Partic ...... Chemotherapy for Breast Cancer

@en

prefLabel

Effect of Unblinding on Partic ...... Chemotherapy for Breast Cancer

@ast

Effect of Unblinding on Partic ...... Chemotherapy for Breast Cancer

@en

P1476

Effect of Unblinding on Partic ...... Chemotherapy for Breast Cancer

@en

P2093

Ann H Partridge

http://www.w3.org/2001/XMLSchema#string

Anne O'Neill

http://www.w3.org/2001/XMLSchema#string

Bryan P Schneider

http://www.w3.org/2001/XMLSchema#string

Chau T Dang

http://www.w3.org/2001/XMLSchema#string

Christine Motley

http://www.w3.org/2001/XMLSchema#string

Donald W Northfelt

http://www.w3.org/2001/XMLSchema#string

George W Sledge

http://www.w3.org/2001/XMLSchema#string

Karen Sepucha

http://www.w3.org/2001/XMLSchema#string

Kathy D Miller

http://www.w3.org/2001/XMLSchema#string

Ramona F Swaby

http://www.w3.org/2001/XMLSchema#string

P2860

Reactions to treatment debriefing among the participants of a placebo controlled trial.

Informing participants of allocation to placebo at trial closure: postal survey.

Placebo effects in oncology.

A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer

A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group.

Assessing participant-centered outcomes to improve clinical research.

Lay public's understanding of equipoise and randomisation in randomised controlled trials.

Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence

Participants' experiences of being debriefed to placebo allocation in a clinical trial.

Bevacizumab: in first-line treatment of metastatic breast cancer.

P304

369-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAONCOL.2015.0246

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26114161

http://www.w3.org/2001/XMLSchema#string

P932

4477538

http://www.w3.org/2001/XMLSchema#string